Fibrosis retroperitoneal

EMC - Urología - Tập 55 - Trang 1-10 - 2023
F. Audenet1, D. Joly2, M.-O. Timsit1, A. Méjean1
1Service d’urologie, Hôpital européen Georges-Pompidou, AP–HP, Université Paris-Cité, 20, rue Leblanc, 75015 Paris, France
2Service de néphrologie adulte, Hôpital Necker, AP–HP, Université Paris-Cité, Paris, France

Tài liệu tham khảo

Vaglio, 2006, Retroperitoneal fibrosis, Lancet, 367, 241, 10.1016/S0140-6736(06)68035-5 Corradi, 2007, Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis, Kidney Int, 72, 742, 10.1038/sj.ki.5002427 Tanaka, 2020, Current approach to diagnosis and management of retroperitoneal fibrosis, Int J Urol, 27, 387, 10.1111/iju.14218 Vaglio, 2016, Idiopathic retroperitoneal fibrosis, J Am Soc Nephrol, 27, 1880, 10.1681/ASN.2015101110 Zen, 2009, Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4, Am J Surg Pathol, 33, 1833, 10.1097/PAS.0b013e3181b72882 Khosroshahi, 2013, Rethinking Ormond's disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease, Medicine, 92, 82, 10.1097/MD.0b013e318289610f Lian, 2016, IgG4-related retroperitoneal fibrosis: a newly characterized disease, Int J Rheum Dis, 19, 1049, 10.1111/1756-185X.12863 Rossi, 2017, Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease, Intern Emerg Med, 12, 287, 10.1007/s11739-016-1599-z Albarran, 1905, Rétention rénale par périurétérite. Libération externe de l’uretère, Assoc Fr Urol, 9, 511 Ormond, 1948, Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process, J Urol, 59, 1072, 10.1016/S0022-5347(17)69482-5 van Bommel, 2009, Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation, Medicine, 88, 193, 10.1097/MD.0b013e3181afc420 Uibu, 2004, Asbestos exposure as a risk factor for retroperitoneal fibrosis, Lancet, 363, 1422, 10.1016/S0140-6736(04)16100-X Miller, 2003, Presentation of idiopathic retroperitoneal fibrosis in the pediatric population, J Pediatr Surg, 38, 1685, 10.1016/S0022-3468(03)00590-6 Goldoni, 2014, Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study, Ann Intern Med, 161, 181, 10.7326/M13-2648 Kasashima, 2008, Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis, Am J Surg Pathol, 32, 197, 10.1097/PAS.0b013e3181342f0d Gilkeson, 1996, Retroperitoneal fibrosis. A true connective tissue disease, Rheum Dis Clin North Am, 22, 23, 10.1016/S0889-857X(05)70260-X Hamano, 2002, Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis, Lancet, 359, 1403, 10.1016/S0140-6736(02)08359-9 Zaidan, 2011, The case: a 69-year-old man with a 10-year history of idiopathic retroperitoneal fibrosis, Kidney Int, 80, 1379, 10.1038/ki.2011.357 Umehara, 2012, A novel clinical entity. IgG4-related disease (IgG4RD): general concept and details, Mod Rheumatol, 22, 1, 10.3109/s10165-011-0508-6 Umehara, 2017, Current approach to the diagnosis of IgG4-related disease–Combination of comprehensive diagnostic and organ-specific criteria, Mod Rheumatol, 27, 381, 10.1080/14397595.2017.1290911 Umehara, 2012, Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), Mod Rheumatol, 22, 21, 10.3109/s10165-011-0571-z Okazaki, 2012, Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan, Int J Rheumatol, 2012, 357071, 10.1155/2012/357071 Stone, 2012, IgG4-related disease, N Engl J Med, 366, 539, 10.1056/NEJMra1104650 Lin, 2010, IgG4-related retroperitoneal fibrosis: the first reported case in a Chinese population, Int J Rheum Dis, 13, e70, 10.1111/j.1756-185X.2010.01543.x Thomas, 1973, Retroperitoneal fibrosis associated with malignant disease, Br J Cancer, 28, 453, 10.1038/bjc.1973.171 Urban, 2015, Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach, Rev Med Interne, 36, 15, 10.1016/j.revmed.2014.10.008 Chen, 2019, Retroperitoneal fibrosis secondary to non-urology carcinomas: a clinical and outcome analysis of 97 cases, Clin Transl Oncol, 21, 373, 10.1007/s12094-018-1936-y Kim, 2018, Mediastinal and retroperitoneal fibrosis as a manifestation of breast cancer metastasis: a case report and literature review, Medicine, 97, e11842, 10.1097/MD.0000000000011842 Burbidge, 2013, The role of CT and staging laparoscopy in the staging of gastric cancer, Clin Radiol, 68, 251, 10.1016/j.crad.2012.07.015 Modlin, 2004, Carcinoid tumors and fibrosis: an association with no explanation, Am J Gastroenterol, 99, 2466, 10.1111/j.1572-0241.2004.40507.x Koep, 1977, The clinical significance of retroperitoneal fibrosis, Surgery, 81, 250 Agarwal, 2004, Diagnosis and management of pergolide-induced fibrosis, Mov Disord, 19, 699, 10.1002/mds.20200 Waters, 1989, Hydralazine, hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report, J Urol, 141, 936, 10.1016/S0022-5347(17)41059-7 Finan, 1981, Renal papillary necrosis and retroperitoneal fibrosis secondary to analgesic abuse, J Urol, 126, 533, 10.1016/S0022-5347(17)54612-1 Kottra, 1996, Retroperitoneal fibrosis, Radiol Clin North Am, 34, 1259, 10.1016/S0033-8389(22)00700-X Seth, 2001, Retroperitoneal fibrosis: a rare complication of Pott's disease, J Urol, 166, 622, 10.1016/S0022-5347(05)66007-7 Monev, 2002, Idiopathic retroperitoneal fibrosis: prompt diagnosis preserves organ function, Cleve Clin J Med, 69, 160, 10.3949/ccjm.69.2.160 Moul, 1992, Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma, J Urol, 147, 124, 10.1016/S0022-5347(17)37155-0 Rabbani, 2003, Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma, Urology, 62, 1092, 10.1016/S0090-4295(03)00770-2 Hautekeete, 1990, Retroperitoneal fibrosis after surgery for aortic aneurysm in a patient with periarteritis nodosa: successful treatment with corticosteroids, J Intern Med, 228, 533, 10.1111/j.1365-2796.1990.tb00274.x Serratrice, 2000, “Coated aorta”: a new sign of Erdheim-Chester disease, J Rheumatol, 27, 1550 Vaglio, 2005, Chronic periaortitis: a spectrum of diseases, Curr Opin Rheumatol, 17, 34, 10.1097/01.bor.0000145517.83972.40 Demko, 1997, Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations, J Am Soc Nephrol, 8, 684, 10.1681/ASN.V84684 Vaglio, 2003, Evidence of autoimmunity in chronic periaortitis: a prospective study, Am J Med, 114, 454, 10.1016/S0002-9343(03)00056-1 Baker, 1987, Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases, Br J Urol, 60, 497, 10.1111/j.1464-410X.1987.tb05028.x Kardar, 2002, Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration, J Urol, 168, 550, 10.1016/S0022-5347(05)64677-0 Marcolongo, 2004, Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases, Am J Med, 116, 194, 10.1016/j.amjmed.2003.08.033 Vaglio, 2002, ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis?, J Intern Med, 251, 268, 10.1046/j.1365-2796.2002.00948.x Kukuk, 2015, Retroperitoneal fibrosis: development of a biomarker profile for diagnosis and therapy monitoring, Urologe A, 54, 52, 10.1007/s00120-014-3713-z Vivas, 2000, Retroperitoneal fibrosis: typical and atypical manifestations, Br J Radiol, 73, 214, 10.1259/bjr.73.866.10884739 Saldino, 1972, Medial placement of the ureter: a normal variant which may simulate retroperitoneal fibrosis, J Urol, 107, 58, 10.1016/S0022-5347(17)61083-8 Arrivé, 1989, Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging, Radiology, 172, 139, 10.1148/radiology.172.1.2740497 Rosenkrantz, 2012, Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma, Am J Roentgenol, 199, 118, 10.2214/AJR.11.7822 Bakir, 2014, Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study, Radiology, 272, 438, 10.1148/radiol.14131565 Vaglio, 2005, (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis, Arthritis Rheum, 53, 122, 10.1002/art.20914 Nakatani, 2012, Utility of FDG PET/CT in IgG4-related systemic disease, Clin Radiol, 67, 297, 10.1016/j.crad.2011.10.011 Yamamoto, 2014, Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist, Nat Rev Rheumatol, 10, 148, 10.1038/nrrheum.2013.183 Ebbo, 2014, Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study, Arthritis Care Res, 66, 86, 10.1002/acr.22058 Tang, 2020, Biomarkers in IgG4-related disease: a systematic review, Semin Arthritis Rheum, 50, 354, 10.1016/j.semarthrit.2019.06.018 Chander, 2002, High 2-deoxy-2-[18F]fluoro-D-glucose accumulation in a case of retroperitoneal fibrosis following resection of carcinoid tumor, Mol Imaging Biol, 4, 363, 10.1016/S1536-1632(02)00021-5 Drieskens, 2002, Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings, Clin Nucl Med, 27, 413, 10.1097/00003072-200206000-00005 Mitchinson, 1970, The pathology of idiopathic retroperitoneal fibrosis, J Clin Pathol, 23, 681, 10.1136/jcp.23.8.681 Mirault, 2012, Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients, Medicine, 91, 242, 10.1097/MD.0b013e31826b1c1d Mitchinson, 1972, Aortic disease in idiopathic retroperitoneal and mediastinal fibrosis, J Clin Pathol, 25, 287, 10.1136/jcp.25.4.287 Wu, 2002, Retroperitoneal fibrosis (Ormond's disease): clinical pathologic study of eight cases, Cancer Control, 9, 432, 10.1177/107327480200900510 Merran, 2004, Primary retroperitoneal tumors in adults, J Radiol, 85, 252, 10.1016/S0221-0363(04)97576-2 Shirkhoda, 1986, Computed tomography of perirenal metastases, J Comput Assist Tomogr, 10, 435 Frederiksen, 2015, Systematic review of the effectiveness of fine-needle aspiration and/or core needle biopsy for subclassifying lymphoma, Arch Pathol Lab Med, 139, 245, 10.5858/arpa.2013-0674-RA Oikarinen, 1988, Modulation of collagen metabolism by glucocorticoids. Receptor-mediated effects of dexamethasone on collagen biosynthesis in chick embryo fibroblasts and chondrocytes, Biochem Pharmacol, 37, 1451, 10.1016/0006-2952(88)90006-8 Kubo, 2016, IgG4-related disease, Int J Rheum Dis, 19, 747, 10.1111/1756-185X.12586 Grotz, 1998, Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids, Lancet, 352, 1195, 10.1016/S0140-6736(05)60533-8 Scheel, 2007, Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis, J Urol, 178, 143, 10.1016/j.juro.2007.03.057 Swartz, 2008, Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil, Clin Nephrol, 69, 260, 10.5414/CNP69260 Binder, 2012, Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis, Ann Rheum Dis, 71, 311, 10.1136/annrheumdis-2011-200148 Moroni, 2006, Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches, Nephrol Dial Transplant, 21, 2485, 10.1093/ndt/gfl228 Alberici, 2013, Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis, Ann Rheum Dis, 72, 1584, 10.1136/annrheumdis-2013-203267 Loffeld, 1993, Tamoxifen for retroperitoneal fibrosis, Lancet, 341, 382, 10.1016/0140-6736(93)90195-M Bourouma, 1997, Treatment of idiopathic retroperitoneal fibrosis with tamoxifen, Nephrol Dial Transplant, 12, 2407, 10.1093/ndt/12.11.2407 Vaglio, 2011, Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial, Lancet, 378, 338, 10.1016/S0140-6736(11)60934-3 Catanoso, 2012, Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis, Clin Exp Rheumatol, 30, 776 Loricera, 2014, Tocilizumab in refractory aortitis: study on 16 patients and literature review, Clin Exp Rheumatol, 32, S79 Wallwork, 2018, Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis, Medicine, 97, e12631, 10.1097/MD.0000000000012631 Urban, 2020, Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients, Ann Rheum Dis, 79, 433, 10.1136/annrheumdis-2019-216258 Brandt, 2015, Therapy of retroperitoneal fibrosis: functional therapeutic outcome, Urologe A, 54, 62, 10.1007/s00120-014-3712-0 Bourdoumis, 2014, The use of a thermoexpandable metal alloy stent in the minimally invasive management of retroperitoneal fibrosis: a single center experience from the United kingdom, J Endourol, 28, 96, 10.1089/end.2013.0332 Lodde, 2005, Uretero-ureterocutaneostomy (wrapped by omentum), BJU Int, 95, 371, 10.1111/j.1464-410X.2005.05302.x Kamihira, 2014, A new treatment for retroperitoneal fibrosis: initial experiences of using Seprafilm® to wrap the ureter, BJU Int, 114, 563, 10.1111/bju.12701 Arvind, 2014, Laparoscopic ureterolysis and omental wrapping in patients with retroperitoneal fibrosis and obstructive uropathy: a single-center experience, J Laparoendosc Adv Surg Tech A, 24, 159, 10.1089/lap.2013.0242 Fugita, 2002, Laparoscopic treatment of retroperitoneal fibrosis, J Endourol, 16, 571, 10.1089/089277902320913251 Cristian, 2015, Management of idiopathic retroperitoneal fibrosis from the urologist's perspective, Ther Adv Urol, 7, 85, 10.1177/1756287214565637 O’Brien, 2017, Contemporary role of ureterolysis in retroperitoneal fibrosis: treatment of last resort or first intent? An analysis of 50 cases, BJU Int, 120, 556, 10.1111/bju.13915 Tambyraja, 2004, Ruptured inflammatory abdominal aortic aneurysm: insights in clinical management and outcome, J Vasc Surg, 39, 400, 10.1016/j.jvs.2003.07.029 Sasaki, 1997, Inflammatory abdominal aortic aneurysms and atherosclerotic abdominal aortic aneurysms--comparisons of clinical features and long-term results, Jpn Circ J, 61, 231, 10.1253/jcj.61.231 Jois, 2004, Chronic periaortitis, Rheumatology, 43, 1441, 10.1093/rheumatology/keh326 Sakalihasan, 2005, Abdominal aortic aneurysm, Lancet, 365, 1577, 10.1016/S0140-6736(05)66459-8 Bonati, 2003, Long-term outcome after inflammatory abdominal aortic aneurysm repair: case-matched study, World J Surg, 27, 539, 10.1007/s00268-003-6706-4 von Fritschen, 1999, Inflammatory abdominal aortic aneurysm: a postoperative course of retroperitoneal fibrosis, J Vasc Surg, 30, 1090, 10.1016/S0741-5214(99)70048-0 Kunkler, 1998, Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease, Br J Urol, 82, 147, 10.1046/j.1464-410x.1998.00603.x Jendro, 2004, Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil, Clin Rheumatol, 23, 52, 10.1007/s10067-003-0801-7